Adverum Other Operating Expenses from 2010 to 2026
| ADVM Stock | USD 4.36 0.00 0.00% |
Other Operating Expenses | First Reported 2012-12-31 | Previous Quarter 49.9 M | Current Value 47 M | Quarterly Volatility 14.9 M |
Check Adverum Biotechnologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Adverum Biotechnologies' main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.8 M, Interest Expense of 3.2 M or Selling General Administrative of 76.2 M, as well as many indicators such as Price To Sales Ratio of 101, Dividend Yield of 0.0 or PTB Ratio of 1.23. Adverum financial statements analysis is a perfect complement when working with Adverum Biotechnologies Valuation or Volatility modules.
Adverum | Other Operating Expenses | Build AI portfolio with Adverum Stock |
Latest Adverum Biotechnologies' Other Operating Expenses Growth Pattern
Below is the plot of the Other Operating Expenses of Adverum Biotechnologies over the last few years. Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Adverum Biotechnologies. It is also known as Adverum Biotechnologies overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. It is expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production. Adverum Biotechnologies' Other Operating Expenses historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Adverum Biotechnologies' overall financial position and show how it may be relating to other accounts over time.
| Other Operating Expenses | 10 Years Trend |
|
Other Operating Expenses |
| Timeline |
Adverum Other Operating Expenses Regression Statistics
| Arithmetic Mean | 80,368,338 | |
| Geometric Mean | 38,252,974 | |
| Coefficient Of Variation | 73.57 | |
| Mean Deviation | 50,601,535 | |
| Median | 79,693,000 | |
| Standard Deviation | 59,124,733 | |
| Sample Variance | 3495.7T | |
| Range | 159.4M | |
| R-Value | 0.87 | |
| Mean Square Error | 879.3T | |
| R-Squared | 0.76 | |
| Slope | 10,235,250 | |
| Total Sum of Squares | 55931.7T |
Adverum Other Operating Expenses History
About Adverum Biotechnologies Financial Statements
Adverum Biotechnologies investors utilize fundamental indicators, such as Other Operating Expenses, to predict how Adverum Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Other Operating Expenses | 161.2 M | 93.7 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in services. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adverum Biotechnologies. If investors know Adverum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adverum Biotechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Adverum Biotechnologies is measured differently than its book value, which is the value of Adverum that is recorded on the company's balance sheet. Investors also form their own opinion of Adverum Biotechnologies' value that differs from its market value or its book value, called intrinsic value, which is Adverum Biotechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adverum Biotechnologies' market value can be influenced by many factors that don't directly affect Adverum Biotechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adverum Biotechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Adverum Biotechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adverum Biotechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.